0
0
LOS ANGELES — A groundbreaking study led by researchers at UCLA Health has identified a powerful link between long-term exposure to the agricultural pesticide chlorpyrifos and a significantly elevated risk of Parkinson’s disease. The research, published in the journal Molecular Neurodegeneration, found that individuals living in proximity to areas where the chemical was heavily used faced more than a 2.5-fold increase in their likelihood of developing the debilitating neurological condition.
By combining decades of California residential data with sophisticated laboratory models, the study provides some of the strongest evidence to date that environmental toxins play a primary role in the “Parkinson’s pandemic.” The findings not only highlight the lingering dangers of past pesticide use but also pinpoint the specific biological “cleanup” failure in brain cells that allows the disease to take hold.
Tracking the Environmental Footprint
Parkinson’s disease is a progressive movement disorder affecting nearly one million Americans. While genetics are often blamed, researchers have long suspected that the environment is a silent driver.
To investigate this, the UCLA team analyzed data from the Parkinson’s Environment and Genes (PEG) study, comparing 829 people diagnosed with Parkinson’s against 824 healthy residents in California’s Central Valley—a region known for intensive agriculture. By cross-referencing decades of state pesticide application records with the participants’ residential and occupational histories, the researchers could map out a lifetime of exposure.
The results were stark: long-term residential exposure to chlorpyrifos was associated with a 2.5-fold higher risk of the disease.
The “Smoking Gun” in the Lab
While population studies show a correlation, proving that a specific chemical causes a disease requires biological evidence. The UCLA team turned to animal models to find the “smoking gun.”
In the lab, mice were exposed to aerosolized chlorpyrifos for 11 weeks, mimicking the way humans might inhale the chemical drifting from nearby fields. The results mirrored the human disease:
-
Motor Impairment: The mice developed visible movement problems.
-
Cell Loss: They lost significant numbers of dopamine-producing neurons, the same cells that wither away in Parkinson’s patients.
-
Protein Clumping: Their brains showed an accumulation of alpha-synuclein, a “sticky” protein that forms toxic clumps known as Lewy bodies, a hallmark of Parkinson’s.
A “Trash Collection” Failure
The most significant breakthrough came from experiments with zebrafish, which allowed researchers to peer into the microscopic mechanics of the brain. They discovered that chlorpyrifos disrupts autophagy—the body’s internal recycling system that clears out damaged proteins.
“Think of autophagy as the brain’s trash collection service,” says Dr. Jeff Bronstein, professor of Neurology at UCLA Health and the study’s senior author. “When chlorpyrifos stalls that service, the ‘trash’—in this case, the toxic alpha-synuclein protein—builds up until it kills the neuron.”
Crucially, when the researchers used methods to jump-start this cleanup process or manually removed the protein, the neurons survived despite the presence of the pesticide. This suggests that the damage is not just an accidental side effect, but a specific pathway that could potentially be blocked with future medications.
Public Health Implications and Expert Perspectives
Chlorpyrifos was once one of the most widely used pesticides in the world. While the U.S. Environmental Protection Agency (EPA) banned its use in residential settings in 2001 and moved to restrict agricultural use in 2021, the chemical remains in use on various crops and persists in many international markets.
Medical experts not involved in the study emphasize that the findings are a wake-up call for long-term monitoring.
“This isn’t just about what is being sprayed today; it’s about the legacy of what was sprayed 20 years ago,” says Dr. Elena Rossi, a neurologist specializing in movement disorders (who was not part of the UCLA research). “For people who lived in farming communities during the height of chlorpyrifos use, these findings suggest they may need closer neurological screening as they age.”
Limitations and Counterarguments
While the study is robust, experts note some limitations. The research focuses heavily on residential proximity, which is a proxy for exposure rather than a direct measurement of pesticide levels in the blood or tissue over decades. Additionally, farmers and residents are often exposed to a “cocktail” of different pesticides, making it difficult to isolate the effects of a single chemical entirely.
Industry groups have historically argued that when applied according to strict safety guidelines, chlorpyrifos exposure levels remain below the threshold of human harm. However, the UCLA study’s use of inhalation models suggests that even low-level, chronic exposure may be more toxic to the brain than previously understood.
What This Means for You
For the general public, the study underscores the importance of understanding environmental history. If you have lived for extended periods in agricultural regions where heavy pesticide use was common, it may be worth discussing your neurological health with a primary care provider, especially if you notice early symptoms such as:
-
Slight tremors in hands or fingers.
-
Slowed movement or “heaviness” in the limbs.
-
Changes in handwriting (becoming smaller or cramped).
-
Loss of smell or chronic constipation.
“The goal isn’t to cause panic,” says Dr. Bronstein. “The goal is to identify who is at risk so we can eventually intervene before the damage becomes irreversible.”
Reference Section
Peer-Reviewed Study:
-
Hasan, K. M. M., Barnhill, L. M., Paul, K. C., et al. (2025). “The pesticide chlorpyrifos increases the risk of Parkinson’s disease.” Molecular Neurodegeneration. DOI: 10.1186/s13024-025-00915-z.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
